Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jan 27:15:1503025.
doi: 10.3389/fneur.2024.1503025. eCollection 2024.

Intravenous push administration of anti-seizure medications

Affiliations
Review

Intravenous push administration of anti-seizure medications

Raniah Aljadeed et al. Front Neurol. .

Abstract

Intravenous push (IVP) administration of anti-seizure medications is becoming increasingly popular among emergency departments. IVP administration eliminates the need for compounding and preparation by the pharmacy department, as well as the need to gather infusion materials or set up a patient's tubing and pump, all of which translate to faster drug administration. This is important given the time-sensitive nature of status epilepticus treatment. This review will discuss several anti-seizure medications, including phenytoin, fosphenytoin, valproic acid, levetiracetam, brivaracetam and lacosamide, for which evidence supports the safe and efficacious use of IV push administration.

Keywords: Antiepileptic drugs; antiseizure medications; intravenous push; seizure; status epilepticus.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

    1. Glauser T, Shinnar S, Gloss D, Alldredge B, Arya R, Bainbridge J, et al. . Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American epilepsy society. Epilepsy Curr. (2016) 16:48–61. doi: 10.5698/1535-7597-16.1.48, PMID: - DOI - PMC - PubMed
    1. Hill CE, Parikh AO, Ellis C, Myers JS, Litt B. Timing is everything: where status epilepticus treatment fails. Ann Neurol. (2017) 82:155–65. doi: 10.1002/ana.24986, PMID: - DOI - PMC - PubMed
    1. Sairanen JJ, Kantanen AM, Hyppölä HT, Kälviäinen RK. Treatment delay in status epilepticus - more effective prehospital symptom recognition warranted. Scand J trauma Resusc Emerg Med. (2019) 27:605. doi: 10.1186/s13049-019-0605-7, PMID: - DOI - PMC - PubMed
    1. Gaínza-Lein M, Fernández IS, Ulate-Campos A, Loddenkemper T, Ostendorf AP. Timing in the treatment of status epilepticus: from basics to the clinic. Seizure. (2019) 68:22–30. doi: 10.1016/j.seizure.2018.05.021, PMID: - DOI - PubMed
    1. Cheng JY. Latency to treatment of status epilepticus is associated with mortality and functional status. J Neurol Sci. (2016) 370:290–5. doi: 10.1016/j.jns.2016.10.004, PMID: - DOI - PubMed

LinkOut - more resources